News and Insights from Our Multidisciplinary Team of Experts
Frost & Sullivan News Release: Flagship Biosciences Recognized by Frost & Sullivan for Its Industry-leading AI-powered cTA® Platform for Predictive Diagnostics Santa Clara, CA, September 18, 2018 – Based on its recent analysis of the global market for...
September 10, 2018 – A pathology AI system with an intended use for clinical diagnostics (Dx), prognostics (Px) or companion diagnostics (CDx) can be commercialized as a medical device. Commercialization as a medical device requires: The pathology AI system to be...
August 27, 2018 – Enabling Healthcare Big Data for Pathology requires moving from single-purpose, single-value pathology data to general-purpose rich information data for tissue. Manual Microscopy, the current standard of care in Pathology where a pathologist examines...
August 13, 2018 – Tissue Image Analysis is a 3-step process: Histology Lab, Digital Pathology (DP) and Pathology AI (Artificial Intelligence). Histology laboratories create histology slides by processing, embedding, sectioning, and staining tissue specimens taken from...
July 15, 2018 – Over the past few years, deep learning has created quite a hype about artificial intelligence (AI), and healthcare AI has become a hot topic. Advancements in AI technology for digital pathology may unravel some of the most challenging real-world tissue...
July 30, 2018 – If you are a pharma or biotech company, a tissue bank, or a reference or specialty lab, how do you choose your tissue image analysis technology or service provider? Even if you were the world’s top technology expert, how could you evaluate a vendor who...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
PUBLICATIONS/POSTERS
Abstract Multiplexed analysis of limited tissue samples can improve our understanding of tumor biology and the tumor microenvironment. Chromogenic and fluorescent multiplexed immunohistochemistry (IHC) approaches are available and offer great insights while conserving...
Abstract Using immunohistochemistry (IHC) to examine immune infiltrates in tissue biopsy samples to support exploratory investigations for immuno-oncology drug development is critical for understanding the abundance and spatial relationships of different immune cell...
Key takeaways The RNAscope® platform enabled duplex chromogenic in situ hybridization (CISH) assay visualization of mRNA targets from multiple cell types and biomarkers Quantification of individual and dual cell positivity within tissue compartments Spatial biology...
EVENTS
Flagship presented three posters at the show, including: #AACR2021 poster no. 433: Clinical Validation of a Dickkopf-1 (DKK1) Chromogenic In-situ Hybridization (CISH) Assay for Manual and Image Analysis Assisted Pathologist Interpretation, in partnership with Leap...
SITC 2020 November 9-14, 2020As we prepare our poster presentation for the (virtual) Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting, we encourage you to register now (members register for FREE!)
Join Flagship Biosciences and our partners Gestalt Diagnostics for this informative webinar featuring an overview and discussion of the value of a truly integrated, digital pathology platform, using Artificial Intelligence (AI) to aid in diagnostic decisions! Flagship...